Expression of malaria parasite invasion associated proteins in the sporozoite novel vaccination strategy

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/406701

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Efforts to develop vaccines against malaria still represent a substantial focus of current research activities. Antigens present in the erythrocytic pathogenic stages of the infection account for the majority of targets investigated for potential vaccines. Experimental vaccines targeting the pre-erythrocytic stages [the sporozoite injected by the mosquito, and the hepatic stage parasite) have encompassed a lesser diversity of parasite antigens]. This is the case despite the fact that experimentally induced sterile long-lasting immunity in humans has so far only been achieved through exposure to irradiated sporozoites. The acquisition and maintenance of this immunity depends on the use of invasive sporozoites and on the presence of developmentally arrested hepatic stage parasites.

Funded Activity Details

Start Date: 01-01-2007

End Date: 01-01-2008

Funding Scheme: NHMRC Strategic Awards

Funding Amount: $202,000.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical Parasitology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Malaria | vaccination

Related Links